Fri, 26th Nov 2021 12:59
Silence Therapeutics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says last day of trading of shares on AIM will be Monday, and delisting to be effective from Tuesday. Will retain listing of American Depositary Shares on the Nasdaq Global Market.
Current stock price: 533.00 pence, down 3.1% on Friday
Year-to-date change: up 3.7%
By Lucy Heming;Â lucyheming@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced o...
TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note
(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the...
IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics
